CD44 Genotypes Are Associated with Susceptibility and Tumor Characteristics in Colorectal Cancer Patients

Author:

Márquez-González Rosa María1,Saucedo-Sariñana Anilú Margarita1,Barros-Núñez Patricio2,Gallegos-Arreola Martha Patricia3,Pineda-Razo Tomás Daniel4,Marin-Contreras María Eugenia5,Flores-Martínez Silvia Esperanza1,Sánchez-Corona José1,Rosales-Reynoso Mónica Alejandra1

Affiliation:

1. Molecular Medicine Division, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS)

2. Research Unit of Metabolic Diseases, Pediatric UMAE, Instituto Mexicano del Seguro Social (IMSS)

3. Genetic Division, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS)

4. Medical Oncology Service, Specialty Hospital, Instituto Mexicano del Seguro Social (IMSS)

5. Gastroenterology Service, Specialty Hospital, Instituto Mexicano del Seguro Social (IMSS)

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference59 articles.

1. American Society of Clinical Oncology (2019) Guidelines by clinical area, gastrointestinal cancer. https://www.asco.org/research-guidelines/quality-guidelines/guidelines [Accessed: August 24, 2019].

2. Atashzar, M.R., Baharlou, R., Karami, J., Abdollahi, H., Rezaei, R., Pourramezan, F. & Zoljalali Moghaddam, S.H. (2020) Cancer stem cells: a review from origin to therapeutic implications. J. Cell. Physiol., 235, 790-803.

3. Basakran, N.S. (2015) CD44 as a potential diagnostic tumor marker. Saudi Med. J., 36, 273-279.

4. Bitaraf, S.M., Mahmoudian, R.A., Abbaszadegan, M., Mohseni Meybodi, A., Taghehchian, N., Mansouri, A., Forghanifard, M.M., Memar, B. & Gholamin, M. (2018) Association of two CD44 polymorphisms with clinical outcomes of gastric cancer patients. Asian Pac. J. Cancer Prev., 19, 1313-1318.

5. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. & Jemal, A. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394-424.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3